Cosmetic manufacturers can sometimes violate the law by marketing a cosmetic product with a drug claim or marketing a drug product as a cosmetic, failing to comply with regulatory requirements for drugs. FDA has the authority to regulate cosmetic labeling claims.
On January 13, the FDA published the Interagency Working Group on Asbestos in Consumer Products IWGACP white paper, IWGACP Scientific Opinions on Testing Methods for Asbestos in Cosmetic Products Containing Talc including Talc Intended for Use in Cosmetics.
/PRNewswire/ Today, the U.S. Food and Drug Administration released a white paper developed by the Interagency Working Group on Asbestos in Consumer Products.
The goal was to improve the sensitivity and consistency of analyses and inter-laboratory concurrence relevant to reporting asbestos and similar particles in talc that could potentially affect cosmetic product safety.
/PRNewswire/ Today, the U.S. Food and Drug Administration released a white paper developed by the Interagency Working Group on Asbestos in Consumer Products.